Rubicon Organics Inc. (ROMJ.V)

CAD 0.4

(-1.25%)

Long Term Debt Summary of Rubicon Organics Inc.

  • Rubicon Organics Inc.'s latest annual long term debt in 2023 was - CAD , down -100.0% from previous year.
  • Rubicon Organics Inc.'s latest quarterly long term debt in 2024 Q1 was 74.08 Thousand CAD , down 0.0% from previous quarter.
  • Rubicon Organics Inc. reported annual long term debt of 9.4 Million CAD in 2022, up 4.41% from previous year.
  • Rubicon Organics Inc. reported annual long term debt of 9 Million CAD in 2021, up 3971.9% from previous year.
  • Rubicon Organics Inc. reported quarterly long term debt of 74.08 Thousand CAD for 2024 Q1, down 0.0% from previous quarter.
  • Rubicon Organics Inc. reported quarterly long term debt of 9.9 Million CAD for 2023 Q3, up 4.85% from previous quarter.

Annual Long Term Debt Chart of Rubicon Organics Inc. (2023 - 2016)

Historical Annual Long Term Debt of Rubicon Organics Inc. (2023 - 2016)

Year Long Term Debt Long Term Debt Growth
2023 - CAD -100.0%
2022 9.4 Million CAD 4.41%
2021 9 Million CAD 3971.9%
2020 221.13 Thousand CAD -97.37%
2019 8.4 Million CAD 188.71%
2018 2.91 Million CAD -1.18%
2017 2.94 Million CAD 2629.41%
2016 107.96 Thousand CAD 0.0%

Peer Long Term Debt Comparison of Rubicon Organics Inc.

Name Long Term Debt Long Term Debt Difference
Aequus Pharmaceuticals Inc. 583.58 Thousand CAD 100.0%
CanadaBis Capital Inc. 5.91 Million CAD 100.0%
Decibel Cannabis Company Inc. 32.34 Million CAD 100.0%
Delivra Health Brands Inc. 1.78 Million CAD 100.0%
Entourage Health Corp. 5.79 Million CAD 100.0%
Lifeist Wellness Inc. 868.65 Thousand CAD 100.0%
Cannara Biotech Inc. 39.73 Million CAD 100.0%
Medicure Inc. 229 Thousand CAD 100.0%
PharmaCielo Ltd. 2.55 Million CAD 100.0%
BioSyent Inc. 1.03 Million CAD 100.0%
Voyageur Pharmaceuticals Ltd. 40 Thousand CAD 100.0%